1. Market Research
  2. > All Companies
  3. > TrovaGene, Inc. (TROV) - Medical Equipment - Deals and Alliances Profile

Summary

TrovaGene, Inc. (TrovaGene), formally Xenomics, Inc. is a development stage molecular diagnostic company. It develops and commercializes proprietary diagnostic technologies for screening and monitoring of various diseases. The company’s proprietary urine-based molecular diagnostic tests are used in detection of transrenal DNA (TrDNA) and RNA (TrRNA). The technology is used in tumor detection and monitoring, prenatal genetic testing, infectious diseases, tissue transplantation, forensic identification, and for patient selection in clinical trials. It out-licenses its transrenal technologies to extend oncogene mutation detection using urine as a sample. The company has worldwide rights to worldwide rights to nucleophosmin-1 (NPM1), an informative biomarker for acute myelogenous leukemia (AML) and mutations in the SF3B1 gene. TrovaGene is headquartered in California, the US.

TrovaGene operates with the strategic intent of developing and marketing molecular diagnostic products in the areas of markets cancer treatment, infectious disease, transplantation, and prenatal diagnostics based on transrenal cell-free nucleic acid technology. In line with this objective the company establishes and nourishes collaborations with several research institutes and companies. Recently the company entered into collaborations with Dana-Farber Cancer Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute for the advancement of its candidates.

TrovaGene, Inc. (TROV) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

TrovaGene, Inc. (TROV) - Medical Equipment - Deals and Alliances Profile
Table of Contents
Table of Contents 2
List of Tables 4
List of Figuress 5
TrovaGene, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 6
TrovaGene, Inc., Medical Equipment Deals By Type, 2009 to YTD 2015 7
TrovaGene, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 8
TrovaGene, Inc., Medical Equipment, Deals By Market, 2009 to YTD 2015 9
TrovaGene, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 10
TrovaGene, Inc., Medical Equipment, Deal Details 11
Asset Purchase 11
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 11
Venture Financing 13
TrovaGene Raises US$6.6 Million In Venture Financing 13
Partnerships 14
Trovagene Enters Into Licensing Agreement with GenSignia IP 14
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 15
TrovaGene Enters Into Licensing Agreement With Brunangelo Falini 16
TrovaGene Enters Into An Agreement With Skyline Diagnostics 17
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 18
TrovaGene Enters Into RandD Agreement With PerkinElmer Health Sciences 19
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 21
Equity Offering 22
Trovagene Completes Public Offering of Shares for USD23 Million 22
Trovagene Completes Private Placement Of Shares For US$15 Million 24
Trovagene Completes Private Placement Of Units For US$4 Million 26
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 27
TrovaGene, Inc. - Key Competitors 29
Key Employees 30
Locations And Subsidiaries 31
Head Office 31
Other Locations and Subsidiaries 31
Recent Developments 32
Strategy And Business Planning 32
Jan 21, 2015: Trovagene Expands Collaboration with Genomac to Demonstrate Clinical Utility in Lung and Colorectal Cancer Treatment Monitoring 32
Jan 12, 2015: Trovagene Collaborates with UC San Diego Moores Cancer Center to Demonstrate Clinical Utility of Detecting and Monitoring EGFR Mutations in Lung Cancer Patients 33
Jun 30, 2014: Trovagene Enters Into a Strategic Alliance with the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute 34
Mar 19, 2014: Trovagene and Catholic Health Initiatives Center for Translational Research Partner to Clinically Evaluate Non-Invasive Genomic Diagnostics to Improve Cancer Care 35
Financial Announcements 36
Mar 12, 2015: Trovagene Reports Fourth Quarter and Full Year 2014 Financial Results 36
Nov 06, 2014: Trovagene Announces Third Quarter 2014 Financial Results 38
Aug 07, 2014: Trovagene Announces Second Quarter 2014 Financial Results 39
May 12, 2014: Trovagene Announces First Quarter 2014 Financial Results 40
Mar 17, 2014: Trovagene Reports Fourth Quarter and Full Year 2013 Financial Results 41
Corporate Communications 43
Mar 18, 2015: Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer 43
Jan 06, 2015: Former President of BIO Joins Trovagene's Board of Directors 44
Sep 17, 2014: Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 45
Aug 12, 2014: Leader in Targeted Drug Development, Peter Hirth, Ph.D., Joins Trovagene's Scientific Advisory Board 46
Mar 26, 2014: Genomics and Molecular Diagnostics Pioneer Charles Cantor, Ph.D., Joins Trovagene's Scientific Advisory Board 47
Feb 19, 2014: Dr. Rodney S. Markin Joins Trovagene's Board of Directors 48
Government and Public Interest 49
Jan 26, 2015: Trovagene's Chief Scientific Officer to Present Precision Cancer Monitoring Platform Overview at the Personalized Medicine World Conference 49
Product News 50
Feb 09, 2015: Clinical Results Demonstrate High Sensitivity of Trovagene's Urine-Based HPV Assay for the Detection of High Risk HPV and Pre-Cancerous Cervical Lesions 50
Jan 20, 2015: Clinical Study Results Presented at the 2015 ASCO GI Support Utility of Trovagene's Precision Cancer Monitoring Platform in Colorectal and Pancreatic Cancer Patients 51
Dec 04, 2014: Trovagene Announces Presentation of Clinical Data at the 56th American Society of Hematology Annual Meeting 53
Oct 01, 2014: Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 54
Aug 25, 2014: Clinical Results Presented for Trovagene's Urine-Based High-Risk HPV Assay. 55
Jun 02, 2014: Oncogene Mutation Signal in Urinary Cell Free DNA is Highly Correlated with Treatment Response 56
Clinical Trials 57
Feb 09, 2015: Clinical Results Demonstrate High Sensitivity of Trovagene's Urine-Based HPV Assay for the Detection of High Risk HPV and Pre-Cancerous Cervical Lesions 57
Aug 25, 2014: Clinical Results Presented for Trovagene's Urine-Based High-Risk HPV Assay. 58
Other Significant Developments 59
Jan 08, 2015: Trovagene and City of Hope Collaborate To Monitor EGFR Mutational Status in Lung Cancer Patients 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60

List of Tables
TrovaGene, Inc., Medical Equipment, Key Facts, 2014 1
TrovaGene, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 6
TrovaGene, Inc., Medical Equipment Deals By Type, 2009 to YTD 2015 7
TrovaGene, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 8
TrovaGene, Inc., Deals By Market, 2009 to YTD 2015 9
TrovaGene, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 10
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 11
TrovaGene Raises US$6.6 Million In Venture Financing 13
Trovagene Enters Into Licensing Agreement with GenSignia IP 14
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 15
TrovaGene Enters Into Licensing Agreement With Brunangelo Falini 16
TrovaGene Enters Into An Agreement With Skyline Diagnostics 17
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 18
TrovaGene Enters Into RandD Agreement With PerkinElmer Health Sciences 19
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 21
Trovagene Completes Public Offering of Shares for USD23 Million 22
Trovagene Completes Private Placement Of Shares For US$15 Million 24
Trovagene Completes Private Placement Of Units For US$4 Million 26
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 27
TrovaGene, Inc., Key Competitors 29
TrovaGene, Inc., Key Employees 30
TrovaGene, Inc., Other Locations 31

List of Figuress
TrovaGene, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 1
TrovaGene, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 1
TrovaGene, Inc., Medical Equipment, Deals By Market, 2009 to YTD 2015 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 6
TrovaGene, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 7
TrovaGene, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 8
TrovaGene, Inc., Medical Equipment, Deals by Market, 2009 to YTD 2015 9

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.